Pathway Medical Technologies Introduces Jetstream G2 NXT

 

August 10, 2009—Pathway Medical Technologies, Inc. (Kirkland, WA) announced the market launch of the Jetstream G2 NXT, a 7-F–compatible version of its peripheral atherectomy catheter. The device is based on the company's catheter technology that is capable of treating the entire spectrum of disease found in patients who have peripheral arterial disease (PAD), including hard and soft plaque, calcium, fibrotic lesions, and thrombus. The Jetstream G2 NXT is designed to remove plaque in the lower limbs, restore blood flow, and effectively treat PAD. It is ergonomically designed to maximize treatment effectiveness and offer nonsurgical candidate patients the benefits of a minimally invasive treatment option, including faster recovery and decreased systemic complications, the company stated.

"The 7-F–compatible Jetstream G2 NXT is nearly identical to Jetstream G2 but has the advantages associated with smaller sheath technology," commented Robert Bersin, MD. "As such, it expands my ability to treat more anatomies and patients with varying degrees of PAD."
 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.